Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950103-21-015264
Filing Date
2021-10-01
Accepted
2021-10-01 17:43:48
Documents
2
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 dp159023_3-oren.html 3  
1 dp159023_3-oren.xml 3 1626
2 EXHIBIT 24 dp159022_ex24.htm EX-24 6313
  Complete submission text file 0000950103-21-015264.txt   9298
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Oren Ilan (Reporting) CIK: 0001643073 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40782 | Film No.: 211300214